We are live on ! Find out more
CASI

CASI Pharmaceuticals
CASI

Delisted

CASI was delisted on the 25th of February, 2026.

Back to rankings

28 hedge funds and large institutions have $2.25M invested in CASI Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

17% more capital invested

Capital invested by funds: $1.92M → $2.25M (+$323K)

7% less funds holding

Funds holding: 30 → 28 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WSCM
Wellington Shields Capital Management
New York
+$93K
2
RJFSA
Raymond James Financial Services Advisors
Florida
+$53.4K
3
MHP
Manatuck Hill Partners
Connecticut
+$14.6K
4
MC
Moors & Cabot
Massachusetts
+$13.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.23K

Top Sellers

1
VKH
Virtu KCG Holdings
New York
-$14K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13K
3
Citadel Advisors
Citadel Advisors
Florida
-$2.54K
4
BFA
BlackRock Fund Advisors
California
-$2.09K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
– +$19 +2 +33%
1
2